Partial correlation analysis revealed that the ANXA2 expression was not associated with the gender (P = 0.871), age (P = 0.656), pathologic type (P = 0.699), clinical stage (P = 0.126), tumor status (P = 0.663), lymph node status (P = 0.151), distal metastasis status (P = 0.330) and recurrence (P = 0.704), but correlated with prognosis in NPC patients (P = 0.036) (Table 1). This evidence concerns the gene ANXA2 and nasopharyngeal carcinoma.